References
- amfAR, International AIDS Vaccine Initiative (IAVI), Johns Hopkins University – Center for Public Health and Human Rights (JHU-CPHHR), United Nations Development Programme (UNDP). (2015). Respect, protect, fulfill: best practices guidance in conducting HIV research with gay, bisexual, and other men who have sex with men (MSM) in rights constrained environments. Retrieved August 8, 2018 from https://www.avac.org/sites/default/files/resource-files/RespectProtectFulfill2015.pdf
- Ammann, A. (2016). Inequalities in clinical research. The Lancet, 388(10062), 2868–2869. https://doi.org/10.1016/S0140-6736(16)32396-0
- Asian Pacific Sex Workers Network. (2007). Making sex work safe in Asia and the Pacific. 27 April. http://apnsw.org/apnsw.htm.
- Bain, L. E., Ebuenyi, I. D., Ekukwe, N. C., & Awah, P. K. (2018). Rethinking research ethics committees in low- and medium-income countries. Research Ethics, 14(1), 1–7. https://doi.org/10.1177/1747016117692026
- Barditch-Crovo, P., Deeks, S. G., Collier, A., Safrin, S., Coakley, D. F., Miller, M., Kearney, B. P., Coleman, R. L., Lamy, P. D., Kahn, J. O., McGowan, I., & Lietman, P. S. (2001). Phase I/II Trial of the pharmacokinetics, safety, and antiretroviral activity of Tenofovir Disoproxil Fumarate in human immunodeficiency virus-infected adults. Antimicrobial Agents and Chemotherapy, 45(10), 2733–2739. https://doi.org/10.1128/AAC.45.10.2733-2739.2001
- Benatar, S. R. (2000). Avoiding exploitation in clinical research. Cambridge Quarterly of Healthcare Ethics, 9(4), 562–565. https://doi.org/10.1017/S096318010000414X
- Brown, B., Marg, L., Zhang, Z., Kuzmanović, D., Dubé, K., & Galea, J. (2019). Factors associated with payments to research participants: A review of sociobehavioral studies at a Large Southern California Research University. Journal of Empirical Research on Human Research Ethics, 1–8. https://doi.org/10.1177/1556264619869538.
- Buchanan, J. M. (1975). The limits of liberty: Between anarchy and Leviathan. Number 714. University of Chicago Press.
- Burman, E. (1990). Differing with deconstruction: A feminist critique. In I. Parker & J. Shotter (Eds.), Deconstructing social psychology (pp. 208–221). Routledge.
- Carpenter-Song, E., & Whitley, R. (2013). Behind the scenes of a research and training collaboration: Power, privilege, and the hidden transcript of race. Culture, Medicine, and Psychiatry, 37(2), 288–306. https://doi.org/10.1007/s11013-013-9311-5
- Centers for Disease Control and Prevention. (2011). Principles of community engagement. 2nd ed. Retrieved February 22, 2019 from http://www.atsdr.cdc.gov/communityengagement/pdf/PCE_Report_508_FINAL.pdf National Institutes of Health Research; 2011
- Chigwedere, E., Mkunthi, M., Ukpong, M., Peterson, K., Nthete, E., & Obileye, O. (2010). Saying ‘no’ to clinical research: Malawi’s denial to study Tenofovir (TDF) PreP.Poster presentation at the 18th IAS AIDS Conferencein Vienna, Austria. 18th to 23rd July, 2010 (Poster ThPE0249).
- Chua, A., Ford, N., Wilson, D., & Cawthorne, P. (2005). The Tenofovir pre-exposure prophylaxis trial in Thailand: Researchers should show more openness in their engagement with the community. PLoS Medicine, 2(10), e346. https://doi.org/10.1371/journal.pmed.0020346
- Clark, P. F., & Sadler, J. (2010). Role of labor unions in labor markets. Chapter 16. In R. C. Free (Ed.), 21st century economics: A reference handbook (pp. 163). SAGE.https://doi.org/10.4135/9781412979290.
- Collins, C. (2005). Gaps and inconsistencies in ethical guidance for HIV prevention research. Background paper prepared for UNAIDS. UNAIDS.
- Cooper, M. (2013). Double exposure: Sex workers, biomedical prevention trials and the dual logic of global public health. S&F Online, 11(3). http://sfonline.barnard.edu/life-un-ltd-feminism-bioscience-race/double-exposure-sex-workers-biomedical-prevention-trials-and-the-dual-logic-of-global-public-health/
- Council for International Organizations of Medical Sciences (CIOMS). (2016). International ethical guidelines for health related research involving human subjects.
- d’Agostino, F., Gaus, G., & Thrasher, J. (1996). Contemporary approaches to the social contract. Stanford Encyclopedia of Philosophy.
- Darwell, S. (2008). Contractarianism/contractualism. Blackwell Publishing.
- Denny, C. C., & Grady, C. (2007). Clinical research with economically disadvantaged populations. Journal of Medical Ethics, 33(7), 382–385. https://doi.org/10.1136/jme.2006.017681
- Fairhead, J., Leach, M., & Small, M. (2006). Where techno-science meets poverty: Medical research and the economy of blood in the Gambia, West Africa. Social Science and Medicine, 63(4), 1109–1120. https://doi.org/10.1016/j.socscimed.2006.02.018
- Fehintola, F. A., Akinyinka, O. O., Adewole, I. F., Maponga, C. C., Ma, Q., & Morse, G. D. (2011). Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa. Current Drug Metabolism, 12(1), 51–56. https://doi.org/10.2174/138920011794520008
- Finlay, L. (2002). “Outing” the researcher: The provenance, process, and practice of reflexivity. Qualitative Health Research, 12(4), 531–545. https://doi.org/10.1177/104973202129120052
- Folayan, M. O., & Allman, D. (2011). Clinical trials as an industry and an employer of labour. Journal of Cultural Economy, 4(1), 97–104. https://doi.org/10.1080/17530350.2011.535376
- Folayan, M. O., Falobi, O., Faleyimu, B., & Ogunlayi, M. (2011). Standard of care for HIV prevention technology research: A consensus document from Nigeria. African Journal of Medicine and Medical Sciences, 40(3), 265–271. PMID: 22428522.
- Forbes, A., & Sanushka, M. (2009). Preventing prevention trial failures: a case study and lessons for future trials from the 2004 Tenofovir trial in Cambodia. In M. Ukpong & K. Peterson (Eds.), Oral Tenofovir Controversy II. NVHMAS. http://www.nhvmas-ng.org/publication/TDF2.pdf
- Gaus, G., & Thrasher, J. (2016). Rational choice in the original position: The (many) models of rawls and harsanyi. In T. Hinton (Ed.), The Original position (pp. 39–58). Cambridge University Press.https://doi.org/10.1017/CBO9781107375321.003.
- Gill, R. (1998). Dialogues and differences: Writing, reflexivity and the crisis of representation. In K. Henwood, C. Griffin, & A. Phoenix (Eds.), Standpoints and differences: Essays in the practice of feminist psychology (pp. 18–43). Sage.
- Global Campaign for Microbicides. (2005). Rethinking the ethical roadmap for clinical testing of microbicides: Report on an international consultation . Global Campaign for Microbicides. PATH USA.
- Global Campaign for Microbicides. (2009). Research Rashomon: Lessons from the Cameroon pre-exposure prophylaxis trial site. Global Campaign for Microbicides. PATH USA.
- Grady, C. (2005). Payment of clinical research subjects. Journal of Clinical Investigation, 115(7), 1681–1687. https://doi.org/10.1172/JCI25694
- Grant, R. M., Buchbinder, S., Cates Jr, W., Clarke, E., Coates, T. Cohen, M. S., Delaney, M., Flores, G., Goicochea, P., Gonsalves, G., Harrington, M., Lama, J. R., MacQueen, K. M., Moore, J. P., Peterson, L., Sanchez, J., Thompson, M., & Wainberg, M. A. (2005). AIDS: Promote HIV chemoprophylaxis research, don't prevent It. Science, 309(5744), 2170–2171. https://doi.org/10.1126/science.1116204
- Greed, C. (1990). The Professional and the personal. A study of women quantity surveyors. In L. Stanley (Ed.), Feminist Praxis. Research theory and epistemology in feminist sociology (pp. 145–159). Routledge.
- HIV/AIDS Network Coordination, Community Partners – National Institutes of Health. (2014). Recommendations for community engagement in HIV/AIDS research. Retrieved February 22, 2019 from https://www.hanc.info/cp/resources/Documents/Recommendations%202014%20FINAL%206-5-14%20rc.pdf
- HIV/AIDS Network Coordination (HANC). (2014). Recommendations for Community Engagement in HIV/AIDS Research. Retrieved August 1, 2016 from https://www.hanc.info/cp/resources/Documents/Recommendations%202014%20FINAL%206-5-14%20rc.pdf
- HPTN. (2009). HIV Prevention Trials Network Ethics Guidance for Research. Retrieved March 3, 2019 from https://www.hptn.org/sites/default/files/2016-05/HPTNEthicsGuidanceV10Jun2009_0.pdf
- Inter Academy Council. (2012). Responsible Conduct in the Global Research Enterprise. Inter Academy Council Secretariat. Retreived 26 February, 2019 from http://www.interacademies.net/file.aspx?id=19789
- International AIDS Society (IAS). (2005). Building collaboration to advance HIV prevention - Global consultation on Tenofovir pre-exposure prophylaxis research: Report of a consultation convened by the International AIDS Society on behalf of the Bill and Melinda Gates Foundation. US National Institutes of Health and US Centers for Disease Control.
- Janes, H., Gilbert, P., Buchbinder, S., Kublin, J., Sobieszczyk, M. E., Hammer, S. M. (2013). In pursuit of an HIV vaccine: Designing Efficacy trials in the context of partially effective nonvaccine prevention modalities. AIDS Research and Human Retroviruses, 29(11), 1513–1523. https://doi.org/10.1089/aid.2012.0385
- Jintakarnon, S., Nakapiew, S., Tienudom, N., Suwannawong, P., & Wilson, D. (2005). Unethical clinical trials in Thailand: A community response. The Lancet, 365(9471), 1617–1618. https://doi.org/10.1016/S0140-6736(05)66501-4
- Joint United Nations Programme on HIV ⁄ AIDS (UNAIDS), Global Advocacy for HIV Prevention (AVAC). (2007). UNAIDS / 07.30E / JC1364E. Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (1st ed.). UNAIDS. http://whqlibdoc.who.int/unaids/2007/9789291736348_eng.pdf.
- Kalai, E., & Smorodinsky, M. (1975). Other solutions to Nash’s bargaining problem. Econometrica: Journal of the Econometric Society, 43(3), 513–518. https://doi.org/10.2307/1914280
- Kaplan, K. (2009). The Thailand story. In M. Ukpong & K. Peterson (Eds.), Oral Tenofovir Controversy II. NVHMAS. http://www.nhvmas-ng.org/publication/TDF2.pdf
- Krubiner, C. B., & Hyder, A. A. (2014). A bioethical framework for health systems activity: A conceptual exploration applying ‘systems thinking’. Health Systems. https://doi.org/10.1057/hs.2014.1
- Lange, J. M. A. (2005). We must not let protestors derail trials of pre-exposure prophylaxis for HIV. PLoS Medicine, 2(9), e248. https://doi.org/10.1371/journal.pmed.0020248
- Lynch, H., Joffe, S., Thirumurthy, H., Xie, D., & Largent, E. (2019). Association between financial incentives and participant deception about study eligibility. JAMA Network Open, 2(1), e187355. https://doi.org/10.1001/jamanetworkopen.2018.7355
- Macklin, R. (1981). 'Due' and 'undue' inducements: On pasing money to research subjects. IRB: Ethics and Human Research, 3(5), 1–6. https://doi.org/10.2307/3564136
- MacQueen, K. M., & Auerbach, J. D. (2018). It is not just about “the trial”: The critical role of effective engagement and participatory practices for moving the HIV research field forward. Journal of the International AIDS Society, 21(Suppl. 7), e25179. https://doi.org/10.1002/jia2.25179
- Macqueen, K. M., Harlan, S. V., Selvin, K. W., Hannah, S., Bass, E., & Moffett, J. (2012). Stakeholder engagement toolkit for HIV prevention trials. FHI.
- Mellors, S. (2005). Towards creating effective partnerships for the conduct of HIV prevention trials: Perspectives from regional consultations held in Southern Africa, Western and Eastern Africa and South East Asia. UNAIDS.
- Michael, M., & Rosengarten, M. (2013). Innovation and biomedicine: Ethics, evidence and expectation in HIV. Palgrave Macmillan.
- Miller, L., Folayan, M., Allman, D., Nkala, B., Kasirye, L. M., Mingote, L. R., Calazans, G., Mburu, R., Ntombela, F., & Ditmore, M. (2010). How ethical is your clinical trial? International Journal of Clinical Practice, 64(9), 1179–1182. https://doi.org/10.1111/j.1742-1241.2010.02421.x
- Mills, E., Rachlis, B., Wu, P., Wong, E., Wilson, K., & Singh, S. (2005). Media reporting of Tenofovir trials in Cambodia and Cameroon. BMC International Health and Human Rights, 5(1), 6. https://doi.org/10.1186/1472-698X-5-6
- Moehler, M. (2018). Minimal morality: A multilevel social contract theory. Oxford University Press.
- Muldoon, R., Lisciandra, C., Colyvan, M., Martini, C., Sillari, G., & Sprenger, J. (2014). Disagreement behind the veil of ignorance. Philosophical Studies, 170(3), 377–394. https://doi.org/10.1007/s11098-013-0225-4
- Nash, Jr., J. F. (1950). The bargaining problem. Econometrica: Journal of the Econometric Society, 18, 155–162. https://doi.org/10.2307/1907266
- Nelson, R. H. (1953). The momentum theory of goodwill. The Accounting Review, 28(4), 491–499.
- Njue, M., Kombe, F., Mwalukore, S., Molyneux, S., & Marsh, V. (2014). What are fair study benefits in international health research? Consulting community members in Kenya. PLoS ONE, 9(12), e113112. https://doi.org/10.1371/journal.pone.0113112
- Oakeshott, M. (1962). Rationalism in politics and other essays. Basic Books.
- Parker, M., & Kingori, P. (2016). Good and Bad research collaborations: Researchers’ Views on science and ethics in global Health research. PLoS One, 13(11(10)), e0163579. https://doi.org/10.1371/journal.pone.0163579.
- Permalink. (2018). Colonialism, whiteness, and free speech: Power and the erasure of voice. Care: Center for culture-centered approach to research and evaluation. Retrieved March 3, 2019 from http://tur-www1.massey.ac.nz/~wwcare/2018/09/20/colonialism-whiteness-and-free-speech-power-and-the-erasure-of-voice/
- Permuth-Wey, J., & Borenstein, A. R. (2009). Financial remuneration for clinical and behavioral research participation: Ethical and practical considerations. Annals of Epidemiology, 19(4), 280–285. https://doi.org/10.1016/j.annepidem.2009.01.004
- Peterson, K., & Folayan, M. O. (2019). Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria. Bioethics, 33(1), 35–42. https://doi.org/10.1111/bioe.12470
- Peterson, K., Folayan, M. O., Chigwedere, E., & Nthete, E. (2015). Saying ‘No’ to PrEP research in Malawi: What constitutes ‘failure’ in offshored HIV prevention research? Anthropology & Medicine, 22(3), 278–294. https://doi.org/10.1080/13648470.2015.1081377
- Peterson, L., Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanda, K., Grant, R., Kekawo Clarke, E. E., Doh, A. S., Ridzon, R., Jaffe, H. S., Cates, W. (2007). Tenofovirdisoproxilfumarate for preventin of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clinical Trials, 2(5), e27. https://doi.org/10.1371/journal.pctr.0020027
- Peterson, K., & Ukpong, M. (2008, August 3rd – 8th). Ethical misrecognition: Reframing community perspectives and debates on clinical trial conduct. 2008. Poster Abstract presentation at the XVII International AIDS conference in Mexico City (Poster Presentation - MOPE1088).
- Peterson, K., & Ukpong, M. (2013). Ethical misrecognition: The early PrEP tenofovir trial failures. Symposium presentation at the Second International HIV Social Sciences and Humanities Conference, Paris, France, July 10, 2013.
- Philpott, S., Heise, L., McGrory, E., Paxton, L., & Hankins, C. (2011). The challenge of defining standards of prevention in HIV prevention trials. Journal of Medical Ethics, 37(4), 244–248. https://doi.org/10.1136/jme.2010.037176
- Rennie, S., Sugarman, J., Abdool Karim, Q., & Ethics Working Group, HIV Prevention Trials Network. (2010, July 8). Updated ethics guidancefor HIV prevention research. International AIDS Society conference, Vienna, Austria.
- Resnik, D. B. (2015). Bioethical issues in providing financial incentives to research participants. Medicolegal and Bioethics, 5, 35–41. https://doi.org/10.2147/MB.S70416
- Reynolds, L., Cousins, T., & Newell, M.-L., & Imrie, J. (2013). The social dynamics of consent and refusal in HIV surveillance in rural South Africa. Social Science & Medicine, 77, 118–125. https://doi.org/10.1016/j.socscimed.2012.11.015
- Riley, S., Schouten, W., & Cahill, S. (2003). Exploring the dynamics of subjectivity and power between researcher and researched. Forum: Qualitative Social Research, 4, 2. Art. 40.https://doi.org/10.17169/fqs-4.2.713.
- Rubinstein, A. (1982). Perfect equilibrium in a bargaining model. Econometrica: Journal of the Econometric Society, 50, 97–109. https://doi.org/10.2307/1912531
- Sandy, L. (2012). International agendas and sex worker rights in Cambodia. In M. Ford (Ed.), Social activism in South East Asia (pp. 154–169). Routledge.
- Schaefer, A. (2019). Rationality, uncertainty, and unanimity: An epistemic critique of contractarianism. Cambridge University Press.
- Schneider, N. (2017). Between promise and skepticism: The global south and our role as engaged intellectuals. The Global South, 11(2), 18–38. https://doi.org/10.2979/globalsouth.11.2.02
- Selvin, K.-W., Ukpong, M., & Heise, L. (2008). Community engagement in HIV prevention trials: evolution of the field and opportunities for growth. Aids2031 background paper. Available at: https://www.path.org/publications/files/aids2031_comm_engage.pdf. Accessed 23 July, 2016.
- Singh, J. A., & Mills, E. J. (2005). The abandoned trials of pre-exposure prophylaxis for HIV: What went wrong? PLoS Medicine, 2(9), e234. https://doi.org/10.1371/journal.pmed.0020234
- Slack, C., Wilkinson, A., Salzwedel, J., & Ndebele, P. (2018). Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: Opportunities and complexities. Journal of the International AIDS Society, 21(Suppl 7), e25172. https://doi.org/10.1002/jia2.25172
- Smids, J., & Nyholm, S. (2019). Is being “paid to endure” compatible with autonomy? Paid research participation and Five (rather than Four) Goods of work. The American Journal of Bioethics, 19(9), 41–43. https://doi.org/10.1080/15265161.2019.1630502
- Strine, M. S. (1997). Deconstructing identity in/and difference: Voices “under erasure”. Western Journal of Communication, 61(4), 448–459. https://doi.org/10.1080/10570319709374589
- Sunder Rajan, K. (2017). Pharmocracy: Value, politics, and knowledge in global biomedicine. Duke University Press.
- The Thai AIDS Treatment Action Group (TTAG). (2012). Stakeholder input and recommendations for good participatory practices (GPP) in biomedical HIV prevention trials in Thailand. Retrieved August 1, 2016 from http://www.ttag.info/pdf/EnglishGPPTTAGFinal.pdf.
- Thompson, C. (2013). Good science: The ethical choreography of stem cell research. MIT Press.
- Thompson, M. (2005). The experts speak. Studying the potential of Tenofovir to prevent sexual transmission of HIV: First steps. Interview by Vicki Glaser. AIDS Patient Care and STDs, 19(1), 1–4. https://doi.org/10.1089/apc.2005.19.1
- Ukpong, M. (2009). The Nigeria story. In M. Ukpong & K. Peterson (Eds.), Oral Tenofovir Controversy II: Voices from the field. NHVMAS. http://www.nhvmasng.org/publication/TDF2.pdf.
- Ukpong, M., & Falobi, O. (2005). Phase 2 trial of oral Tenofovir use as A chemoprophylaxis for HIV infection in Nigeria: the outcome of community involvement with the scientific research: Report of the outcome of dialogue between the community and researchers involved with the phase 2 oral tenofovir trial in Nigeria. New HIV Vaccine and Microbicide Advocacy Group, Nigeria. Retrieved September 22, 2017 from https://www.nhvmas-ng.org/publication/tdf.pdf
- Ukpong, M., Fatusi, O., & Peterson, K. (2008). Community vs researcher’s perspectives on community demands from trials. Oral abstract presentation at the Microbicide 2008 Conference at New Delhi, India. February 24th to 27th, 2008 (Oral abstract 123).
- Ukpong, M., & Peterson, K. (2009). Oral Tenofovir Controversy II: Voices from the Field. Lagos: NHVMAS. http://www.nhvmasng.org/publication/TDF2.pdf
- Ukpong, M., Peterson, K., & Akanni, O. (2010). Common decimals on community perspectives of the ethical conduct of clinical trials: a review of the oral Tenofovir controversy. Poster discussion at the Microbicide 2010 held in Pittsburgh, USA. May 22nd to 25th, 2010. (Poster discussion386).
- UNAIDS. (2006). Creating effective partnership for HIV prevention trials: Report of a UNAIDS consultation, Geneva 20–21 June, 2005. AIDS, 20(1), W1–W11. https://doi.org/10.1097/01.aids.0000218573.29930.67
- UNAIDS and AVAC. (2011). Good participatory practice guidelines for biomedical HIV prevention trials. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC1853_GPP_Guidelines_2011_en.pdf
- UNAIDS and WHO. (2007). Ethical considerations in biomedical HIV prevention trials. UNAIDS/WHO guidance document. Geneva, UNAIDS, World Health Organization. Retrieved February 12, 2010 from http://data.unaids.org/pub/Report/2007/jc1399_ethical_considerations_en.pdf
- UNAIDS and WHO. (2012). Ethical considerations in biomedical HIV prevention trials [additional guidance point added in 2012]. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2012/jc1399_ethical_considerations_en.pdf
- Varga-Dobai, K. (2012). The relationship of researcher and participant in qualitative inquiry: From “self and other” binaries to the poststructural feminist perspective of subjectivity. The Qualitative Report, 17(47), 1–17. http://nsuworks.nova.edu/tqr/vol17/iss47/1
- West Slevin, K., Ukpong, M., & Heise, L. (2008). Community Engagement in HIV Prevention Trials: Evolution of the Field and Opportunities for Growth. Aids2031 Science and Technology Working Group, No 11.
- Women’s Network for Unity (WNU). (2004a). Background to WNU Press Conference on Tenofovir Trials in Cambodia on March 29, 2004. http://wnu.womynsagenda.org/documents/wnu29mar04.pdf
- Women’s Network for Unity (WNU) Press statement. (2004b). Women’s Network for Unity Protests Drug Trial Recruitment Tactics. http://www.wnu.womynsagenda.org/documents/wnu21june04.pdf
- Yomgne, C. T. (2009). The Cameroon Story. In M. Ukpong & K. Peterson (Eds.), Oral Tenofovir Controversy II. NVHMAS. http://www.nhvmas-ng.org/publication/TDF2.pdf